UK markets closed

Mirum Pharmaceuticals, Inc. (MIRM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
25.84+0.24 (+0.94%)
At close: 04:00PM EDT
26.35 +0.51 (+1.97%)
After hours: 05:01PM EDT
Show:
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Assets
Current assets
Cash
Cash and cash equivalents
286,326
28,003
31,340
142,086
Other short-term investments
0
123,716
125,201
89,734
Total cash
286,326
151,719
156,541
231,820
Net receivables
67,968
23,994
3,267
0
Inventory
22,312
5,565
1,513
0
Other current assets
10,935
8,947
5,271
4,530
Total current assets
387,541
190,225
166,592
236,350
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,990
2,345
2,550
3,242
Net property, plant and equipment
1,990
2,345
2,550
3,242
Equity and other investments
-
0
4,983
0
Intangible assets
252,925
58,954
18,740
-
Other long-term assets
4,165
101,382
101,786
1,272
Total non-current assets
259,080
162,681
128,059
4,514
Total assets
646,621
352,906
294,651
240,864
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
7,416
8,690
9,166
3,151
Accrued liabilities
50,889
36,902
20,125
8,610
Other current liabilities
-
1,090
1,996
1,264
Total current liabilities
87,064
64,729
42,596
18,462
Non-current liabilities
Long-term debt
306,421
-
-
-
Deferred revenues
0
140,351
129,923
47,651
Other long-term liabilities
3,849
4,532
17
29
Total non-current liabilities
310,887
146,140
131,843
50,307
Total liabilities
397,951
210,869
174,439
68,769
Stockholders' equity
Common stock
5
4
3
3
Retained earnings
-556,239
-392,824
-257,159
-173,171
Accumulated other comprehensive income
1,644
-217
-35
83
Total stockholders' equity
248,670
142,037
120,212
172,095
Total liabilities and stockholders' equity
646,621
352,906
294,651
240,864